Two biotech stocks plunge after losing patent fights

According to a filing from the U.S. Patent and Trademark Office, Forward Pharma has been interfering with Biogen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.